Boston Scientific(BSX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BSX Boston Scientific

Market Closed 03-13 16:00:00 EDT

69.13

+0.58

+0.85%

盘后68.76

-0.37-0.54%

19:59 EDT

High69.60	Low68.41	Vol11.66M
Open68.96	D1 Closing68.55	Amplitude1.73%
Mkt Cap102.48B	Tradable Cap102.14B	Total Shares1.48B
T/O804.33M	T/O Rate0.79%	Tradable Shares1.48B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BSX","market":"US","secType":"STK","nameCN":"Boston Scientific","latestPrice":69.13,"timestamp":1773432000000,"preClose":68.55,"halted":0,"volume":11660823,"hourTrading":{"tag":"盘后","latestPrice":68.76,"preClose":69.13,"latestTime":"19:59 EDT","volume":296282,"amount":20481896.8557,"timestamp":1773446371010,"change":-0.37,"changeRate":-0.005352,"amplitude":0.005352},"delay":0,"changeRate":0.0084609773887673,"floatShares":1477475891,"shares":1482442039,"eps":1.94,"marketStatus":"Market Closed","change":0.58,"latestTime":"03-13 16:00:00 EDT","open":68.96,"high":69.595,"low":68.41,"amount":804327072.16401,"amplitude":0.017287,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.94,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1773648000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":68.55,"preHourTrading":{"tag":"盘前","latestPrice":68.95,"preClose":68.55,"latestTime":"09:29 EDT","volume":2181,"amount":150151.55568000002,"timestamp":1773408598094,"change":0.4,"changeRate":0.005835,"amplitude":0.007002},"postHourTrading":{"tag":"盘后","latestPrice":68.76,"preClose":69.13,"latestTime":"19:59 EDT","volume":296282,"amount":20481896.8557,"timestamp":1773446371010,"change":-0.37,"changeRate":-0.005352,"amplitude":0.005352},"volumeRatio":0.957023146175747,"optionData":{"bulkOrders":[{"symbol":"BSX","call":true,"expireDate":1773979200000,"strike":"74.0","timestamp":1773343656029,"price":0.1,"volume":7200,"amount":72000,"type":"-"},{"symbol":"BSX","call":false,"expireDate":1773979200000,"strike":"87.5","timestamp":1773343781175,"price":19.4,"volume":5750,"amount":11155000,"type":"+"}]},"impliedVol":0.4645,"impliedVolPercentile":0.9721},"requestUrl":"/m/hq/s/BSX","defaultTab":"news","newsList":[{"id":"2619086116","title":"Abbott Laboratories' Structural Heart Business Could See Upside From Watchman Trial Results, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2619086116","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619086116?lang=en_us&edition=fundamental","pubTime":"2026-03-13 23:33","pubTimestamp":1773416003,"startTime":"0","endTime":"0","summary":"Abbott Laboratories'  structural heart business could see \"meaningful upside\" from readout of positive results of Boston Scientific's  clinical trial of the Watchman implant at the end of March, UBS said in a note emailed Friday.Positive trial results could spark a broader growth in the structural heart area that could indirectly lift Abbott's MedTech segment through a modest market capture, UBS analysts said. Their scenario analysis suggests that even small market share gains have the potential to raise the MedTech segment's five-year compound annual growth rate to sustainable double-digit growth levels, compared to the consensus of 9.6% over the 2025-2030 period.Although the company's shares have been down 11% year-to-date from 52-week highs partly due to investors' concerns about deceleration in key growth areas within the MedTech segment, the analysts said they believe that the structural heart division remains \"underappreciated.\"UBS reiterated the company's stock rating at buy and","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0345769128.USD","BK4504","LU0234572021.USD","SG9999002224.SGD","LU0011850046.USD","LU0122379950.USD","LU0058720904.USD","LU0823416689.USD","ABT","LU1983299246.USD","BK4588","LU2211815571.USD","LU1720051017.SGD","IE00BJT1NW94.SGD","BK4581","LU1989772923.USD","LU0187121727.USD","LU2362541513.USD","LU0353189680.USD","LU1914381329.SGD","IE0009355771.USD","IE00BJJMRZ35.SGD","LU0225283273.USD","LU2491049909.HKD","LU2324357040.USD","SG9999001176.USD","LU1721429402.USD","LU1989772840.SGD","LU0868494617.USD","LU2244417387.USD","LU2491050154.USD","LU0432979614.USD","LU0882574055.USD","LU2133065610.SGD","BSX","LU0048584097.USD","LU1718418525.SGD","BK4592","LU0266013472.USD","LU1061106388.HKD","LU1804176565.USD","LU2237957811.SGD","BK4585","LU1691799644.USD","LU2357305700.SGD","IE00BFTCPJ56.SGD","LU1023059063.AUD","LU1989763427.SGD","ABT.AU","BSX.AU"],"gpt_icon":0},{"id":"2618975512","title":"Elutia Q4 revenue rises on higher cardiovascular product sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2618975512","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618975512?lang=en_us&edition=fundamental","pubTime":"2026-03-12 04:26","pubTimestamp":1773260768,"startTime":"0","endTime":"0","summary":"Elutia Q4 revenue rises on higher cardiovascular product salesOverviewDrug-eluting biomatrix maker's Q4 revenue rose 16% yr/yr to $3.3 mlnNet income turned positive, driven by $88 mln BioEnvelope busi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nL1N3ZZ1C5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0353189763.USD","LU2362541273.HKD","LU0114720955.EUR","LU0122379950.USD","BK4082","LU0353189680.USD","IE0002141913.USD","BSX","LU0267386448.USD","LU1989772923.USD","LU1791710582.SGD","LU0048584097.USD","LU0823417737.USD","LU2506952170.USD","LU0823417653.USD","LU2324357040.USD","LU2506951875.HKD","IE0009355771.USD","LU1548497426.USD","ELUT","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","LU0950375773.USD","LU1366192091.USD","LU0238689110.USD","LU2491050071.SGD","LU2491049909.HKD","LU0345769631.USD","SG9999001176.SGD","LU0225283273.USD","IE00BFTCPJ56.SGD","SG9999013999.USD","LU1720051017.SGD","LU2112291526.USD","LU0187121727.USD","LU2362541513.USD","LU2242649171.HKD","LU1804176565.USD","IE00B4R5TH58.HKD","LU2244417387.USD","LU0528227936.USD","LU1153585028.USD","LU1989764664.SGD","LU2506952097.USD","LU1989772840.SGD","LU0882574055.USD","LU2491050154.USD","LU0251132253.USD","LU1720051108.HKD"],"gpt_icon":0},{"id":"2618929484","title":"Boston Scientific Is Maintained at Buy by Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2618929484","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618929484?lang=en_us&edition=fundamental","pubTime":"2026-03-11 23:40","pubTimestamp":1773243600,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BSX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 11, 2026 11:40 ET (15:40 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BSX"],"gpt_icon":0},{"id":"2618948239","title":"Boston Scientific price target lowered to $94 from $102 at Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2618948239","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618948239?lang=en_us&edition=fundamental","pubTime":"2026-03-11 17:27","pubTimestamp":1773221229,"startTime":"0","endTime":"0","summary":"Citi lowered the firm’s price target on Boston Scientific (BSX) to $94 from $102 and keeps a Buy rating on the shares. The firm adjusted targets in...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/boston-scientific-price-target-lowered-to-94-from-102-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/boston-scientific-price-target-lowered-to-94-from-102-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BSX"],"gpt_icon":0},{"id":"2618910440","title":"Baird Adjusts Price Target on Boston Scientific to $95 From $101, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2618910440","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618910440?lang=en_us&edition=fundamental","pubTime":"2026-03-11 17:19","pubTimestamp":1773220751,"startTime":"0","endTime":"0","summary":"Boston Scientific (BSX) has an average rating of buy and mean price target of $103.81, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major b","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BSX"],"gpt_icon":0},{"id":"2618916466","title":"U.S. RESEARCH ROUNDUP-Howmet Aerospace, Nike, Oracle","url":"https://stock-news.laohu8.com/highlight/detail?id=2618916466","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618916466?lang=en_us&edition=fundamental","pubTime":"2026-03-11 15:10","pubTimestamp":1773213002,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Howmet Aerospace, Nike, OracleMarch 11 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies on Wednesday, includin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"73f0b19cff544fe0a24216c0d940c1eb","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nL4N3ZZ0GR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BKNU","HAE","MET","ORCS","PGNY","CNCG","HLT","BMRN","BSX","BKNG","HMYY","BLND","AVR","EXPE","HIYY","ELV","HOG","ORCU","AVXX","ABT","ALMS","ORCL","ADC","GEHC","CHH","CDW","FICO","CLYM","EPRT","APYX","HIMS","REGN","CRBG","DXCM","HIMZ","T","ABM","AVAV","H","CNC","UEC","ORCX","RNA","CASY","HAS","HIMY","SJM","DBI","HWM","NKE"],"gpt_icon":1},{"id":"2618690089","title":"Boston Scientific Corp. Stock Underperforms Tuesday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2618690089","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618690089?lang=en_us&edition=fundamental","pubTime":"2026-03-11 04:39","pubTimestamp":1773175140,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Boston Scientific Corp.  slid 2.70% to $69.96 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.21% to 6,781.48 and Dow Jones Industrial Average  falling 0.07% to 47,706.51.Boston Scientific Corp. closed 36.11% short of its 52-week high of $109.50, which the company achieved on September 9th.The stock underperformed when compared to some of its competitors Tuesday, as Abbott Laboratories  fell 1.86% to $110.55, Medtronic PLC  fell 1.59% to $89.89, and Stryker Corp.  fell 1.99% to $358.65.Trading volume  remained 638,879 below its 50-day average volume of 14.9 M.Data source: Dow Jones Market Data, FactSet. Data compiled March 10, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BSX"],"gpt_icon":0},{"id":"2618575969","title":"Boston Scientific Targets Drug-Resistant Motor Epilepsy With New Deep Brain Stimulation Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2618575969","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618575969?lang=en_us&edition=fundamental","pubTime":"2026-03-11 00:31","pubTimestamp":1773160302,"startTime":"0","endTime":"0","summary":"Boston Scientific ($BSX) announced an update on their ongoing clinical study. Boston Scientific (BSX) is backing a pilot trial called “Combined CM ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/boston-scientific-targets-drug-resistant-motor-epilepsy-with-new-deep-brain-stimulation-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/boston-scientific-targets-drug-resistant-motor-epilepsy-with-new-deep-brain-stimulation-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BSX"],"gpt_icon":0},{"id":"2618616674","title":"Boston Scientific (BSX): CHAMPION AF Trial Poised to Strengthen Watchman Evidence, Broaden Adoption, and Support Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2618616674","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618616674?lang=en_us&edition=fundamental","pubTime":"2026-03-09 11:15","pubTimestamp":1773026122,"startTime":"0","endTime":"0","summary":"Boston Scientific, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Josh Jennings from TD Cowen maintained a Bu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/boston-scientific-bsx-champion-af-trial-poised-to-strengthen-watchman-evidence-broaden-adoption-and-support-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/boston-scientific-bsx-champion-af-trial-poised-to-strengthen-watchman-evidence-broaden-adoption-and-support-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BSX"],"gpt_icon":0},{"id":"2618698725","title":"Class Action Lawsuit Targets Boston Scientific Over Alleged Investor Harm","url":"https://stock-news.laohu8.com/highlight/detail?id=2618698725","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618698725?lang=en_us&edition=fundamental","pubTime":"2026-03-09 00:00","pubTimestamp":1772985620,"startTime":"0","endTime":"0","summary":"A securities class action lawsuit has been filed against Boston Scientific Corporation and certain officers, alleging violations of federal securities laws. The suit seeks damages on behalf of investors who bought or acquired the company’s securities between July 23, 2025 and February 3, 2026, claiming the company made materially false or misleading statements about the sustainability of projected 2025 growth, particularly in its U.S. electrophysiology segment, amid adverse trends and competitive, regulatory, and reimbursement pressures. Investors have until May 4, 2026 to seek appointment as lead plaintiff.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260308:nNDL6xJpnG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823417737.USD","BK4588","IE00BKPKM429.USD","LU1791710400.SGD","LU1989772840.SGD","LU0225283273.USD","LU0950375773.USD","LU0251132253.USD","LU1804176565.USD","LU0353189680.USD","LU2112291526.USD","LU2362540622.SGD","LU0314104364.USD","NDAQ","SG9999014013.SGD","IE0009355771.USD","LU0823416689.USD","LU0238689110.USD","LU0011850046.USD","LU1057294990.SGD","LU1989772923.USD","LU2362541273.HKD","LU1153585028.USD","LU1366192091.USD","BSX","LU0267386448.USD","SGXZ57979304.SGD","LU0122379950.USD","LU0077335932.USD","BK4082","IE00BFTCPJ56.SGD","BK4504","LU1718418525.SGD","LU1989771016.USD","LU2491050154.USD","LU2506951875.HKD","LU2506952097.USD","SG9999013999.USD","BK4581","LU1061106388.HKD","LU1291159041.SGD","LU2265009873.SGD","LU2362541513.USD","LU1983299246.USD","IE0002141913.USD","LU2491050071.SGD","LU2491049909.HKD","IE00B4R5TH58.HKD","LU0823417653.USD","LU2324357040.USD"],"gpt_icon":0},{"id":"2617363120","title":"Boston Scientific’s ENTRUST Registry Targets Real-World Edge in Carotid Stroke Prevention","url":"https://stock-news.laohu8.com/highlight/detail?id=2617363120","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617363120?lang=en_us&edition=fundamental","pubTime":"2026-03-07 00:32","pubTimestamp":1772814747,"startTime":"0","endTime":"0","summary":"Boston Scientific ($BSX) announced an update on their ongoing clinical study. Boston Scientific Corp. is launching the ENTRUST registry, a real-wor...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/boston-scientifics-entrust-registry-targets-real-world-edge-in-carotid-stroke-prevention?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/boston-scientifics-entrust-registry-targets-real-world-edge-in-carotid-stroke-prevention?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1023059063.AUD","LU2491049909.HKD","LU1989772840.SGD","LU1989772923.USD","LU0048584097.USD","LU1791710582.SGD","LU0823417653.USD","LU0266013472.USD","IE0009355771.USD","IE0002141913.USD","LU1989764664.SGD","LU0882574055.USD","LU2362541273.HKD","BSX","LU0114720955.EUR","LU0122379950.USD","LU0238689110.USD","LU2087625088.SGD","LU1061106388.HKD","LU1291159041.SGD","BK4581","LU0011850046.USD","LU0345769128.USD","LU2491050071.SGD","SG9999013999.USD","LU0353189763.USD","LU2112291526.USD","LU2362540622.SGD","LU2357305700.SGD","LU0251132253.USD","LU0077335932.USD","LU0432979614.USD","LU1720051017.SGD","IE00B4R5TH58.HKD","LU0823417737.USD","LU2265009873.SGD","LU2324357040.USD","LU0345769631.USD","LU1057294990.SGD","LU1718418525.SGD","LU2506951875.HKD","BK4504","IE00BJT1NW94.SGD","SG9999001176.SGD","IE00B2B36J28.USD","LU0187121727.USD","LU2242649171.HKD","LU1720051108.HKD","IE00BJJMRZ35.SGD","LU2506952097.USD"],"gpt_icon":0},{"id":"2617680210","title":"**Boston Scientific to webcast investor event at ACC Scientific Session**Boston Scientific will host an investor event and live webcast to discuss key clinical data presented at the 75th Annual Scientific Session of the American College of Cardiology. The webcast and replay will be available at https://investors.bostonscientific.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2617680210","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617680210?lang=en_us&edition=fundamental","pubTime":"2026-03-06 21:01","pubTimestamp":1772802072,"startTime":"0","endTime":"0","summary":"**Boston Scientific to webcast investor event at ACC Scientific Session** Boston Scientific will host an investor event and live webcast to discuss key clinical data presented at the 75th Annual Scien","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nNDL8hVm7b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2087625088.SGD","LU2362540622.SGD","SG9999001176.USD","SGXZ57979304.SGD","LU0114720955.EUR","LU0267386448.USD","BSX","LU0353189763.USD","LU0011850046.USD","LU0432979614.USD","LU1061106388.HKD","LU1791710400.SGD","IE0002141913.USD","BK4588","IE00B2B36J28.USD","LU1153585028.USD","LU1989764748.USD","LU1989771016.USD","LU2112291526.USD","LU0187121727.USD","LU0353189680.USD","LU0528227936.USD","LU1718418525.SGD","LU1291159041.SGD","SG9999001176.SGD","LU2506951958.HKD","LU2491050071.SGD","LU0266013472.USD","LU0823417737.USD","LU2491050154.USD","LU2362541513.USD","LU0345769631.USD","LU0048584097.USD","LU1023059063.AUD","LU2324357040.USD","IE00BJT1NW94.SGD","LU1548497426.USD","LU0823417653.USD","BK4082","LU2242649171.HKD","LU1989772923.USD","BK4581","LU2506952170.USD","LU1983299246.USD","LU0225283273.USD","LU1804176565.USD","LU0251132253.USD","LU2491049909.HKD","IE00BJJMRZ35.SGD","LU2362541273.HKD"],"gpt_icon":0},{"id":"2617579243","title":"Boston Scientific Corp. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2617579243","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617579243?lang=en_us&edition=fundamental","pubTime":"2026-03-06 05:40","pubTimestamp":1772746800,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Boston Scientific Corp.  rose 1.08% to $72.99 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.56% to 6,830.71 and Dow Jones Industrial Average  falling 1.61% to 47,954.74.The stock's rise snapped a three-day losing streak.Boston Scientific Corp. closed 33.34% short of its 52-week high of $109.50, which the company achieved on September 9th.The stock outperformed some of its competitors Thursday, as Abbott Laboratories  fell 1.82% to $111.04, Medtronic PLC  fell 2.71% to $93.01, and Stryker Corp.  fell 2.98% to $370.50.Trading volume  remained 2.1 million below its 50-day average volume of 14.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled March 5, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BSX"],"gpt_icon":0},{"id":"2616551158","title":"Boston Scientific targets net-zero greenhouse gas emissions by 2050 and 50% emissions cuts by 2030","url":"https://stock-news.laohu8.com/highlight/detail?id=2616551158","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616551158?lang=en_us&edition=fundamental","pubTime":"2026-03-04 23:20","pubTimestamp":1772637613,"startTime":"0","endTime":"0","summary":"Boston Scientific Corporation outlined measures to reduce the environmental impact of its medical devices as part of its goal to reach net-zero greenhouse gas emissions by 2050 and to cut emissions 50% by 2030. The company said it is expanding the use of digital instructions for use to reduce paper, applying sustainable packaging principles such as reducing material use and increasing recycled content, and exploring recyclable and renewable materials. It also cited a recycling pilot in Germany that recovered about 1,000 single-use imaging devices in 2024 and noted that LithoVue Elite single-use ureteroscope handles are now made primarily with bio-based plastic, with up to 85% attributed to renewably sourced raw materials.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nNDLcbKC5y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2506952170.USD","BK4504","LU0528227936.USD","LU2087625088.SGD","IE00B4R5TH58.HKD","LU1153585028.USD","IE00BJJMRZ35.SGD","LU2506952097.USD","IE0009355771.USD","LU1989771016.USD","LU0432979614.USD","SG9999013999.USD","BK4581","LU0823416689.USD","IE00BFTCPJ56.SGD","LU1804176565.USD","LU1366192091.USD","LU2506951958.HKD","BK4585","BSX","LU1718418525.SGD","LU1791710582.SGD","LU2244417387.USD","LU2491050071.SGD","LU1061106388.HKD","LU2324357040.USD","LU1023059063.AUD","BK4588","BK4082","LU0077335932.USD","LU2242649171.HKD","LU0353189763.USD","IE00BJT1NW94.SGD","LU1989772923.USD","LU2491049909.HKD","LU2112291526.USD","LU0345769128.USD","LU0823417737.USD","LU1291159041.SGD","LU0823417653.USD","LU0187121727.USD","LU1720051017.SGD","LU0048584097.USD","LU1983299246.USD","LU2357305700.SGD","LU0114720955.EUR","SG9999001176.SGD","LU1057294990.SGD","LU0266013472.USD","LU1720051108.HKD"],"gpt_icon":0},{"id":"2616551122","title":"Boston Scientific call volume above normal and directionally bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2616551122","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616551122?lang=en_us&edition=fundamental","pubTime":"2026-03-04 23:05","pubTimestamp":1772636713,"startTime":"0","endTime":"0","summary":"Bullish option flow detected in Boston Scientific (BSX) with 12,898 calls trading, 4x expected, and implied vol increasing over 6 points to 44.78%....","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/boston-scientific-call-volume-above-normal-and-directionally-bullish-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/boston-scientific-call-volume-above-normal-and-directionally-bullish-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0353189680.USD","BSX","LU0266013472.USD","LU2506952170.USD","LU0345769631.USD","IE00B4R5TH58.HKD","LU0267386448.USD","IE00BJJMRZ35.SGD","LU0823417653.USD","LU1989772840.SGD","LU1804176565.USD","LU1720051017.SGD","LU1791710582.SGD","SGXZ57979304.SGD","LU0187121727.USD","IE00B2B36J28.USD","BK4585","LU0353189763.USD","LU0823417737.USD","LU1366192091.USD","LU0077335932.USD","LU0011850046.USD","LU0122379950.USD","IE00BJT1NW94.SGD","LU2242649171.HKD","LU2362540622.SGD","BK4581","LU2362541513.USD","BK4082","LU1989764664.SGD","LU0882574055.USD","LU0950375773.USD","LU1057294990.SGD","LU2324357040.USD","LU0823416689.USD","LU1291159041.SGD","LU1548497426.USD","LU1983299246.USD","LU2506952097.USD","LU2357305700.SGD","LU1718418525.SGD","SG9999013999.USD","LU0432979614.USD","LU2244417387.USD","LU0238689110.USD","SG9999001176.USD","BK4588","LU2362541273.HKD","LU2491050154.USD","LU0225283273.USD"],"gpt_icon":0},{"id":"2616155572","title":"Portnoy Law Firm Investigates Boston Scientific for Possible Securities Fraud","url":"https://stock-news.laohu8.com/highlight/detail?id=2616155572","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616155572?lang=en_us&edition=fundamental","pubTime":"2026-03-04 22:01","pubTimestamp":1772632874,"startTime":"0","endTime":"0","summary":"The Portnoy Law Firm has opened an investigation into Boston Scientific Corporation over potential securities fraud and is considering a class action on behalf of investors. The probe follows a sharp share-price drop on February 4, 2026 after the company reported fourth-quarter 2025 results that included weaker-than-expected electrophysiology sales.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nNDL6KC24c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","LU0225283273.USD","LU1983299246.USD","LU2491049909.HKD","LU0114720955.EUR","SG9999014021.USD","LU1989772923.USD","LU0345769631.USD","LU2506951875.HKD","LU0048584097.USD","BK4581","LU1057294990.SGD","LU2095319765.USD","LU0528227936.USD","LU2362541273.HKD","SG9999014039.USD","LU1989764664.SGD","LU0251132253.USD","BSX","BK4588","IE00BJJMRZ35.SGD","LU0011850046.USD","LU1989772840.SGD","LU0238689110.USD","LU2265009873.SGD","LU2210150020.SGD","IE00B2B36J28.USD","IE00BKPKM429.USD","LU2506952097.USD","LU2210149790.SGD","LU2491050154.USD","IE0002141913.USD","LU0950375773.USD","LU1153585028.USD","LU0823416689.USD","LU0314104364.USD","LU0353189763.USD","LU2506951958.HKD","NDAQ","IE00B3QW5Z07.USD","SG9999014013.SGD","SGXZ57979304.SGD","IE00B4R5TH58.HKD","LU0267386448.USD","LU1366192091.USD","LU1804176565.USD","LU2362540622.SGD","LU2362541513.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2616537226","title":"China Merchants Initiates Boston Scientific at Buy With $88 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2616537226","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616537226?lang=en_us&edition=fundamental","pubTime":"2026-03-04 20:25","pubTimestamp":1772627137,"startTime":"0","endTime":"0","summary":"Boston Scientific (BSX) has an average rating of buy and mean price target of $104.52, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major b","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BSX"],"gpt_icon":0},{"id":"2616536542","title":"Boston Scientific: Near-Term EP Reset but 2027 Growth Drivers Support Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2616536542","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616536542?lang=en_us&edition=fundamental","pubTime":"2026-03-04 17:55","pubTimestamp":1772618127,"startTime":"0","endTime":"0","summary":"Travis Steed, an analyst from Bank of America Securities, reiterated the Buy rating on Boston Scientific. The associated price target remains the s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/boston-scientific-near-term-ep-reset-but-2027-growth-drivers-support-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/boston-scientific-near-term-ep-reset-but-2027-growth-drivers-support-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BSX","EP"],"gpt_icon":0},{"id":"2616589455","title":"Penumbra Sale To Boston Scientific Puts Focus On Deal Terms And Future","url":"https://stock-news.laohu8.com/highlight/detail?id=2616589455","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616589455?lang=en_us&edition=fundamental","pubTime":"2026-03-04 13:31","pubTimestamp":1772602307,"startTime":"0","endTime":"0","summary":"Penumbra (NYSE:PEN) has entered into a definitive agreement to be acquired by Boston Scientific.\nThe all cash transaction values Penumbra at approximately US$14.5b.\nThe deal is subject to approval by Penumbra shareholders and other customary closing conditions.\n\nPenumbra focuses on medical devices for neurovascular and peripheral vascular conditions, areas that continue to attract attention as populations age and care standards evolve. Boston Scientific’s agreement to acquire NYSE:PEN adds...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-pen/penumbra/news/penumbra-sale-to-boston-scientific-puts-focus-on-deal-terms","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-pen/penumbra/news/penumbra-sale-to-boston-scientific-puts-focus-on-deal-terms","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0345769128.USD","LU0011850046.USD","LU0823416689.USD","LU1983299246.USD","LU2491050071.SGD","SG9999001176.SGD","BK4082","IE00B2B36J28.USD","LU0353189763.USD","LU1720051017.SGD","IE00BJT1NW94.SGD","LU0267386448.USD","BK4581","LU2362541513.USD","LU1791710400.SGD","IE0009355771.USD","IE00BJJMRZ35.SGD","LU0225283273.USD","LU2491049909.HKD","LU0345769631.USD","LU0114720955.EUR","LU0528227936.USD","LU1989771016.USD","IE0002141913.USD","LU2506951958.HKD","LU1989772840.SGD","LU1548497426.USD","LU2244417387.USD","LU0432979614.USD","LU0238689110.USD","LU2506952170.USD","LU2112291526.USD","BSX","PEN","LU2362540622.SGD","LU0266013472.USD","LU1061106388.HKD","LU0823417737.USD","BK4585","LU1057294990.SGD","LU2357305700.SGD","LU1791710582.SGD","LU0251132253.USD","IE00BFTCPJ56.SGD","LU1989764664.SGD","LU1291159041.SGD","LU1720051108.HKD","LU2324357040.USD","IE00B4R5TH58.HKD","LU2506952097.USD"],"gpt_icon":0},{"id":"2616808372","title":"Boston Scientific Corp. Stock Underperforms Tuesday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2616808372","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616808372?lang=en_us&edition=fundamental","pubTime":"2026-03-04 05:39","pubTimestamp":1772573940,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Boston Scientific Corp.  slipped 3.11% to $73.85 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.94% to 6,816.63 and Dow Jones Industrial Average  falling 0.83% to 48,501.27.This was the stock's second consecutive day of losses.Boston Scientific Corp. closed 32.56% short of its 52-week high of $109.50, which the company reached on September 9th.The stock underperformed when compared to some of its competitors Tuesday, as Abbott Laboratories  fell 0.45% to $113.61, Medtronic PLC  fell 1.42% to $96.71, and Stryker Corp.  fell 0.63% to $384.59.Trading volume  eclipsed its 50-day average volume of 14.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled March 3, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswir","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BSX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bostonscientific.com","stockEarnings":[{"period":"1week","weight":-0.0311},{"period":"1month","weight":-0.0591},{"period":"3month","weight":-0.2533},{"period":"6month","weight":-0.3269},{"period":"1year","weight":-0.2751},{"period":"ytd","weight":-0.275}],"compareEarnings":[{"period":"1week","weight":-0.015},{"period":"1month","weight":-0.0429},{"period":"3month","weight":-0.0286},{"period":"6month","weight":0.0074},{"period":"1year","weight":0.2011},{"period":"ytd","weight":-0.0288}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, that uses in the treatment of coronary artery disease and aortic valve conditions. Further, it provides stents, balloon catheters, guidewires, atherectomy, and thrombectomy systems to treat arterial and venous diseases; and peripheral embolization devices, radioactive microspheres, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.617647,"avgChangeRate":0.051947},{"month":2,"riseRate":0.529412,"avgChangeRate":-0.001374},{"month":3,"riseRate":0.558824,"avgChangeRate":0.021805},{"month":4,"riseRate":0.666667,"avgChangeRate":0.018678},{"month":5,"riseRate":0.606061,"avgChangeRate":0.020467},{"month":6,"riseRate":0.5,"avgChangeRate":0.004921},{"month":7,"riseRate":0.617647,"avgChangeRate":0.019016},{"month":8,"riseRate":0.441176,"avgChangeRate":0.003398},{"month":9,"riseRate":0.382353,"avgChangeRate":-0.02534},{"month":10,"riseRate":0.470588,"avgChangeRate":0.00099},{"month":11,"riseRate":0.470588,"avgChangeRate":-0.01032},{"month":12,"riseRate":0.764706,"avgChangeRate":0.036197}],"exchange":"NYSE","name":"Boston Scientific","nameEN":"Boston Scientific"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Boston Scientific(BSX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Boston Scientific(BSX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Boston Scientific,BSX,Boston Scientific股票,Boston Scientific股票老虎,Boston Scientific股票老虎国际,Boston Scientific行情,Boston Scientific股票行情,Boston Scientific股价,Boston Scientific股市,Boston Scientific股票价格,Boston Scientific股票交易,Boston Scientific股票购买,Boston Scientific股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Boston Scientific(BSX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Boston Scientific(BSX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}